Clinical Trials News

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, announced that today the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance with respect to U.S. Patent Application No. 17/151,405, entitled “Compositions and Methods of Use.” The a...

AUSTIN, Texas--(BUSINESS WIRE)--The company is issuing the following corrected version of the release originally distributed on June 9, 2026. In that release, we incorrectly stated that the Phase 2 study reported no treatment‑emergent adverse events. The correct statement is that the study reported no treatment‑related adverse events. No other data from the study are affected by this correction. Zetagen regrets the error and is issuing this clarification to ensure accurate communication. The up...

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the world's largest creator of real-world evidence (RWE) for clinical and medical decision-making, today announced the launch of the Atropos Evidence Agent MCP on the Databricks Marketplace. The release marks the next chapter in the company's partnership with Databricks, first announced in June 2025, and will be showcased at the Databricks Data + AI Summit, June 15–18, 2026, in San Francisco. The Databricks Marketplace is an open marketplace f...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced the election of Jette Nygaard-Andersen to the Company’s Board of Directors after its Annual General Meeting of shareholders on June 10. “We’re pleased to welcome Jette to LivaNova’s Board,” said William Kozy, Chair. “She brings deep medtech governance expertise, proven CEO leadership, and a strong track record of transformation, strategic M&A, and digital innovation across complex gl...

NEW YORK--(BUSINESS WIRE)--For decades, healthcare has become increasingly fragmented and complex, resulting in competing systems that, unintentionally but undeniably, work against the people who matter most: clinicians and their patients. Today at its Keynote event in New York City, Abridge unveiled the first AI-native clinician intelligence platform organized around the patient, built for clinicians, and designed to help health systems coordinate the clinical, financial, and evidence-based de...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new data from a post-hoc subgroup analysis from the pivotal Phase 3 EPCORE® FL-1 trial, evaluating epcoritamab, a subcutaneous T-cell engaging bispecific antibody, in combination with rituximab and lenalidomide (epcoritamab + R2) in adult patients with relapsed or refractory (R/R) follicular lymphoma (FL), which showed that epcoritamab + R2 delivered consistent and sustained efficacy benefits across clinically relev...

KAWASAKI, Japan--(BUSINESS WIRE)--The first patient has been dosed with 64Cu-PD-29875 in a first-in-human clinical study in patients with gastric cancer....

KAWASAKI, Japan--(BUSINESS WIRE)--Completion of patient dosing in the registrational Phase 2 clinical trial of 64Cu-PSMA-I&T —a PET radiopharmaceutical targeting PSMA...

SAN FRANCISCO--(BUSINESS WIRE)--CMHC (Cardiometabolic Health Congress), the premier forum where evidence-based innovation meets clinical practice, unveils the 2026 Conference Program. For over two decades, CMHC has united healthcare providers from around the globe to transform cutting-edge research into actionable strategies that enhance patient care. CMHC uniquely bridges the gap between groundbreaking science and real-world application, empowering a global community of clinicians to transform...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster presentation at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), which will be held June 14 – 17 in Baltimore, MD. The poster presentation details are as follows: Abstract Title Poster Presentation Session Treatment with Pitolisant in Subgroups of Adults with...